You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Effectiveness of azithromycin in aspiration pneumonia: a prospective observational study
|
|---|---|
| Published in |
BMC Infectious Diseases, December 2014
|
| DOI | 10.1186/s12879-014-0685-y |
| Pubmed ID | |
| Authors |
Satoshi Marumo, Takashi Teranishi, Yuichi Higami, Yoshihiko Koshimo, Hirofumi Kiyokawa, Motokazu Kato |
| Abstract |
BackgroundAspiration pneumonia is an urgent health concern with high mortality and long hospitalization in industrialized and aging countries. However, there is no information about the effectiveness of azithromycin (AZM) for the treatment of aspiration pneumonia. This study investigated if AZM is effective for the treatment of aspiration pneumonia.MethodsPatients with aspiration pneumonia with no risk of multidrug-resistant pathogens were included in this prospective study at Kishiwada City Hospital from December 2011 to June 2013. Patients were divided into the ampicillin/sulbactam (ABPC/SBT) and AZM (intravenous injection) groups. The success rates of 1st-line antibiotic therapy, mortality, length of hospital stay, and total antibiotic costs were compared.ResultsThere were 81 and 36 patients in the ABPC/SBT and AZM groups, respectively. There was no significant difference in the success rate of 1st-line antibiotics between the groups (74.1% vs. 75.0%, respectively, P¿=¿1.000). Mortality and hospitalization periods did not differ between the 2 groups (11.1% vs. 8.3%, P¿=¿0.753, and 22.3¿±¿7.3 days vs. 20.5¿±¿8.1 days, P¿=¿0.654, respectively). However, the total antibiotic costs were significantly lower in the AZM group than the ABPC/SBT group (2.19¿±¿1.65¿×¿10,000 yen vs. 2.94¿±¿1.67¿×¿10,000 yen, respectively, P¿=¿0.034). The febrile period of the ABPC/SBT group was significantly shorter than that of the AZM group (P¿=¿0.025).ConclusionsIn this small prospective non-randomized observational study, we found no statistically significant differences in mortality or antibiotic failure in patients receiving AZM compared to ABPC/SBT for the treatment of patients with aspiration pneumonia who require hospital admission and have no risk of drug-resistant pathogens. Therefore, AZM may be another first choice of antibiotic treatment for patients with aspiration pneumonia when they have no risk of multidrug-resistant pathogens. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 1% |
| Unknown | 68 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 10 | 14% |
| Other | 9 | 13% |
| Student > Bachelor | 8 | 12% |
| Student > Master | 8 | 12% |
| Student > Doctoral Student | 4 | 6% |
| Other | 9 | 13% |
| Unknown | 21 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 41% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 10% |
| Biochemistry, Genetics and Molecular Biology | 5 | 7% |
| Nursing and Health Professions | 5 | 7% |
| Agricultural and Biological Sciences | 1 | 1% |
| Other | 2 | 3% |
| Unknown | 21 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2021.
All research outputs
#1,962,549
of 22,774,233 outputs
Outputs from BMC Infectious Diseases
#535
of 7,669 outputs
Outputs of similar age
#29,365
of 361,216 outputs
Outputs of similar age from BMC Infectious Diseases
#11
of 194 outputs
Altmetric has tracked 22,774,233 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,669 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,216 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 194 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.